Originally developed through groundbreaking research at Erasmus University Medical Center, FOXO4-DRI represents a targeted approach to cellular rejuvenation and has shown remarkable promise in preclinical studies for promoting healthspan and addressing age-related cellular dysfunction
Navarro-Pern E, Cabezas-Herrera J, Garca-Cnovas F, et al
Some patients report changes in comfort, mobility, or recovery within the first few weeks, but results vary and should not replace diagnosis, imaging, rehab, or medical treatment
The practical implication: refrigerate, use within the labeled shelf life, and avoid exposing the vial to repeated temperature fluctuation
Poprawa koncentracji i pamici: Niektre badania sugeruj, e DSIP moe mie pozytywny wpyw na funkcje poznawcze